Imfinzi

Recent Articles

RELATED ARTICLES

  1. TYK Medicines
    A blockbuster cancer drug? TYK’s claims go under the microscope
    2410.HK
  2. NEWS WRAP: Hutchmed sells non-core asset to focus on cancer treatment
    0013.HK HCM.US
  3. Cancer drug maker Genfleet joins Hong Kong IPO influx
  4. Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  5. NEWS WRAP: AstraZeneca China president assisting in investigation
    AZN.US
  6. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  7. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva